Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01026844 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: erlotinib
DRUG: hydroxychloroquine

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]